Member access

4-Traders Homepage  >  Shares  >  Berne Stock Exchange  >  Galenica AG    GALN   CH0015536466

GALENICA AG

 (GALN)

0
 SummaryNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Company
Galenica is a pharmaceutical group organized around 4 areas of activities: - supply of logistical services (42.6% of sales): for pharmaceutical companies, retail sales companies, physicians, and hospitals; - sale of pharmaceutical products (33%): OTC medications, prescription drugs,... 
Surperformance© rating of Galenica AG
Trading Rating : Investor Rating :
More about the company
Financials ( CHF)
Sales 2013 3 535 M
EBIT 2013 358 M
Net income 2013 263 M
Debt 2013 502 M
Yield 2013 1,91%
Sales 2014 3 689 M
EBIT 2014 383 M
Net income 2014 288 M
Debt 2014 333 M
Yield 2014 2,06%
PER 2013 15,46
PER 2014 14,49
EV / Sales 2013 1,28x
EV / Sales 2014 1,18x
Capitalization 4 024 M
More Financials
Latest news on GALENICA AG
05/06 GALENICA AG: ex-dividend day for annual dividend
04/08 GALENICA AG: New PDUFA action date announced by the US FDA for Injectafer® New ..
03/12 GALENICA AG: Profits up for the 17th consecutive year in 2012: +13.6% after min..
02/11 GALENICA AG: PA21 dossier submitted for approval to US FDA
01/17 GALENICA AG: Galenica 2012: Good sales performance with profits up on previous ..
01/14GALENICA AG: quaterly sales release
2012 GALENICA AG: PA21 dossier sent for submission to EMA to seek approval in the EU
2012 GALENICA AG: Change in the Corporate Executive Committee of the Galenica Group
2012 GALENICA AG: ex-dividend day for annual dividend
2012 GALENICA AG: Galenica confirms 2011 profit target: at least on par with previou..
2011 GALENICA AG: Children helping children campaign – Amavita supports Swiss Aids C..
2011 GALENICA AG: New Injectafer® (US brand name of Ferinject®) data to be presented..
More news
Forum GALENICA AG
Advertisement
Income Statement Evolution
Galenica AG : Income Statement Evolution
More Financials
EPS Revisions
Galenica AG : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.